Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Testing effectiveness (Phase 2)Study completedNCT01960855
What this trial is testing

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
AbbVie 276
Testing effectiveness (Phase 2)UnknownNCT02005757
What this trial is testing

Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)

Who this might be right for
Rheumatoid Arthritis
Chong Kun Dang Pharmaceutical 60
Post-approval studies (Phase 4)Study completedNCT00828997
What this trial is testing

Effects of Different Antirheumatic Treatments of Arthritis on Antibody Response Following Vaccination Using Prevenar®

Who this might be right for
Rheumatoid ArthritisSpondylarthropathy
Region Skane 505
Not applicableUnknownNCT02434757
What this trial is testing

Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Ronald J. Rapoport, MD 10
Not applicableStudy completedNCT07436494
What this trial is testing

Coronavirus Anxiety in Patients Using Biologic vs Conventional DMARDs

Who this might be right for
COVID-19AnxietyRheumatic Diseases
Bursa City Hospital 200
Large-scale testing (Phase 3)Study completedNCT02584855
What this trial is testing

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 394
Not applicableLooking for participantsNCT04955899
What this trial is testing

Safety of Splenic Stimulation for RA

Who this might be right for
Rheumatoid Arthritis
Galvani Bioelectronics 5
Post-approval studies (Phase 4)Study completedNCT02557100
What this trial is testing

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 80
Not applicableStudy completedNCT01166763
What this trial is testing

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Who this might be right for
Breast Cancer
Carol Fabian, MD 30
Large-scale testing (Phase 3)Looking for participantsNCT03414502
What this trial is testing

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Who this might be right for
Rheumatoid Arthritis
University of Nebraska 400
Large-scale testing (Phase 3)Active Not RecruitingNCT06276998
What this trial is testing

LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 430
Testing effectiveness (Phase 2)Ended earlyNCT00396812
What this trial is testing

Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID) 4
Large-scale testing (Phase 3)Study completedNCT01235507
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Very early researchUnknownNCT04340349
What this trial is testing

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals

Who this might be right for
HydroxychloroquineAntimalarialsEnzyme Inhibitors+1 more
Instituto Nacional de Rehabilitacion 214
Not applicableStudy completedNCT02240888
What this trial is testing

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

Who this might be right for
RASLEVasculitis+3 more
Region Skane 300
Large-scale testing (Phase 3)Study completedNCT02001987
What this trial is testing

Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 139
Post-approval studies (Phase 4)Study completedNCT00563849
What this trial is testing

Leflunomide + Methotrexate in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 74
Not applicableStudy completedNCT04749160
What this trial is testing

Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Saint Etienne 26
Not applicableUnknownNCT04201535
What this trial is testing

Identification of Novel Molecular Targets for Rheumatoid Arthritis Patients

Who this might be right for
Arthritis, RheumatoidBone Erosion
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 160
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Load More Results